Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 1, 2001, Pages 129-137

  Rocchetta, H L ^a   Boylan, C J ^a   Foley, J W ^a   Iversen, P W ^a   Letourneau, D L ^a   McMillian, C L ^a   Contag, P R ^a   Jenkins, D E ^a   Parr T R , Jr ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BIOLUMINESCENCE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; GENE CLUSTER; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEUTROPENIA; NONHUMAN; PLASMID; PRIORITY JOURNAL; TREATMENT OUTCOME; VALIDATION PROCESS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CEFTAZIDIME; CELL COUNT; CEPHALOSPORINS; CIPROFLOXACIN; DIAGNOSTIC IMAGING; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; MUSCULAR DISEASES; NEUTROPENIA; TETRACYCLINE;

EID: 0035164498     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.1.129-137.2001     Document Type: Article

References (27)

1. Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery
2. Electrotransformation in Salmonella typhimurium LT2
3. Noninvasive techniques for studying pathogenic bacteria in the whole animal
4. Use of the green fluorescent protein to rapidly assess viability of E. coli in preserved solutions
5. Evaluation of new antimicrobials in vitro and in experimental animal infections
6. Photonic detection of bacterial pathogens in living hosts
7. Photonic monitoring of infectious disease and gene regulation
8. Visualizing gene expression in living mammals using a bioluminescent reporter
9. Bioluminescent indicators in living mammals
10. Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections
11. Cloning, organization, and expression of the bioluminescence genes of Xenorhabdus luminescens
12. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages
13. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models
14. Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds
15. Enzymes and genes from the lux operons of bioluminescent bacteria
16. Bacterial bioluminescence: Organization, regulation, and application of the lux genes
17. Genetics of bacterial bioluminescence
18. Physiological, biochemical, and genetic control of bacterial bioluminescence
19. Real-time monitoring of Escherichia coli O157:H7 adherence to beef carcass surface tissues with a bioluminescent reporter
20. Nucleotide sequence, expression, and properties of luciferase coded by lux genes from a terrestrial bacterium
21. Antibiotic-induced release of endotoxin: In-vitro comparison of meropenem and other antibiotics
22. Introduction of lax genes into bacteria, a new approach for specific determination of bacteria and their antibiotic susceptibility
23. Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: Delay between killing by ceftazidime and imipenem and release of LPS
24. Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of P-fimbriated Escherichia coli
25. Compound 64716, a new synthetic antibacterial agent
26. Cloning and nucleotide sequences of lux genes and characterization of luciferase of Xenorhabdus luminescens from a human wound